Physician profile
Brian Kyle Barnes
NPI 1528463379
$977.57
in general payments reported to CMS, 2019-2025
11 companies · $63.32 in 2025
The $63.32 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $118 · 2022: $216 · 2023: $417 · 2024: $164 · 2025: $63.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $216.30 | 2023-2025 | |
| Intrinsic Therapeutics | $199.90 | 2023 | Barricaid Acd (Annular Closure Device) |
| Bioventus LLC | $122.42 | 2022 | |
| Medical Device Business Services, INC. | $117.54 | 2021 | |
| Depuy Synthes Sales INC. | $102.42 | 2024-2025 | Conduit, Zero-P Va, Zero-P |
| Pacira Pharmaceuticals Incorporated | $93.67 | 2022 | |
| Nevro Corp. | $49.11 | 2024 | Senza |
| Medtronic, INC. | $22.51 | 2024 | Intellis Adaptivestim |
| Kuros Biosciences USA, INC | $21.82 | 2023 | |
| Heron Therapeutics, INC. | $17.99 | 2024 | Zynrelef |
| Painteq LLC | $13.89 | 2023 | Painteq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.